Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Connect Biopharm Llc

Clinical trials sponsored by Connect Biopharm Llc, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Experimental drug aims to tame severe asthma and COPD attacks Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Completed 2

Experimental drug aims to tame severe asthma and COPD attacks

Disease control Recruiting now

This trial tests a single dose of rademikibart, given intravenously, as an add-on treatment for people hospitalized with an acute asthma or COPD flare-up who also have type 2 inflammation. The study includes 40 adults and measures how well the drug improves lung function and cont…

Phase 2 • Sponsor: Connect Biopharm LLC • Aim: Disease control

Last updated Aug 29, 2026 00:00 UTC